BACKGROUND:Mammographic density is a strong predictor of breast cancer risk. The total amount and the metabolism of endogenous estrogens, e.g., the ratio of 2-hydroxyestrone (2-OHE(1)) and 16α-OHE(1) may influence breast cancer risk. This study examined the association of urinary estrogen metabolites with breast density in premenopausal women. METHODS: Urine samples were collected at baseline and after 2 years, analyzed for 11 estrogen metabolites plus progesterone and testosterone by liquid chromatography mass spectrometry, and adjusted for creatinine levels. Mixed-effects regression was applied to examine the association of estrogens with breast density. RESULTS:Total estrogen metabolites (181 ± 113 vs. 247 ± 165 pmol/mg creatinine, p=0.01) and the 2/16α-OH ratio (8.4 ± 10.4 vs. 13.0 ± 17.1, p=0.02) were lower in the 74 Asian than in the 114 non-Asian women. In adjusted models, positive associations of total estrogen metabolites (p=0.002) and the 2/16α-OHE(1) ratio (p=0.08) with percent density were detected in Asians only. In all women, mammographic density was positively associated with the 2-OH pathway (p=0.01), inversely related to the 16α-OH pathway (p=0.01), and not associated with the 4-OH pathway, testosterone, and progesterone. Results for the size of the dense area weakly reflected the findings for percent density, while associations with the non-dense area were in the opposite direction. CONCLUSIONS: The findings that the 2-OH pathway is associated with higher and the 16α-OH pathway with lower breast density contradicts the hypothesized risk profile of these metabolites, but, if a relation between estrogen metabolites and breast cancer risk exists, it may be mediated through pathways other than mammographic density.
RCT Entities:
BACKGROUND: Mammographic density is a strong predictor of breast cancer risk. The total amount and the metabolism of endogenous estrogens, e.g., the ratio of 2-hydroxyestrone (2-OHE(1)) and 16α-OHE(1) may influence breast cancer risk. This study examined the association of urinary estrogen metabolites with breast density in premenopausal women. METHODS: Urine samples were collected at baseline and after 2 years, analyzed for 11 estrogen metabolites plus progesterone and testosterone by liquid chromatography mass spectrometry, and adjusted for creatinine levels. Mixed-effects regression was applied to examine the association of estrogens with breast density. RESULTS: Total estrogen metabolites (181 ± 113 vs. 247 ± 165 pmol/mg creatinine, p=0.01) and the 2/16α-OH ratio (8.4 ± 10.4 vs. 13.0 ± 17.1, p=0.02) were lower in the 74 Asian than in the 114 non-Asian women. In adjusted models, positive associations of total estrogen metabolites (p=0.002) and the 2/16α-OHE(1) ratio (p=0.08) with percent density were detected in Asians only. In all women, mammographic density was positively associated with the 2-OH pathway (p=0.01), inversely related to the 16α-OH pathway (p=0.01), and not associated with the 4-OH pathway, testosterone, and progesterone. Results for the size of the dense area weakly reflected the findings for percent density, while associations with the non-dense area were in the opposite direction. CONCLUSIONS: The findings that the 2-OH pathway is associated with higher and the 16α-OH pathway with lower breast density contradicts the hypothesized risk profile of these metabolites, but, if a relation between estrogen metabolites and breast cancer risk exists, it may be mediated through pathways other than mammographic density.
Authors: Mellissa Yong; Stephen M Schwartz; Charlotte Atkinson; Karen W Makar; Sushma S Thomas; Katherine M Newton; Erin J Aiello Bowles; Victoria L Holt; Wendy M Leisenring; Johanna W Lampe Journal: Cancer Epidemiol Biomarkers Prev Date: 2010-02 Impact factor: 4.254
Authors: Roni T Falk; Thomas R Fears; Xia Xu; Robert N Hoover; Malcolm C Pike; Anna H Wu; Abraham M Y Nomura; Laurence N Kolonel; Dee W West; Daniel W Sepkovic; H Leon Bradlow; Regina G Ziegler Journal: Cancer Epidemiol Biomarkers Prev Date: 2005-01 Impact factor: 4.254
Authors: Veronica Wendy Setiawan; Christopher A Haiman; Frank Z Stanczyk; Loïc Le Marchand; Brian E Henderson Journal: Cancer Epidemiol Biomarkers Prev Date: 2006-10 Impact factor: 4.254
Authors: A Heather Eliassen; Regina G Ziegler; Bernard Rosner; Timothy D Veenstra; John M Roman; Xia Xu; Susan E Hankinson Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-10-20 Impact factor: 4.254
Authors: Andreas Pettersson; Susan E Hankinson; Walter C Willett; Pagona Lagiou; Dimitrios Trichopoulos; Rulla M Tamimi Journal: Breast Cancer Res Date: 2011-10-21 Impact factor: 6.466
Authors: Gretchen L Gierach; Deesha A Patel; Roni T Falk; Ruth M Pfeiffer; Berta M Geller; Pamela M Vacek; Donald L Weaver; Rachael E Chicoine; John A Shepherd; Amir Pasha Mahmoudzadeh; Jeff Wang; Bo Fan; Sally D Herschorn; Xia Xu; Timothy Veenstra; Barbara Fuhrman; Mark E Sherman; Louise A Brinton Journal: Horm Cancer Date: 2015-03-11 Impact factor: 3.869
Authors: Kimberly A Bertrand; A Heather Eliassen; Susan E Hankinson; Gretchen L Gierach; Xia Xu; Bernard Rosner; Regina G Ziegler; Rulla M Tamimi Journal: Breast Cancer Res Treat Date: 2012-09-28 Impact factor: 4.624